Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)(COMPLETED)
This study has been completed.
Study NCT00231790 Information provided by Merck Sharp & Dohme Corp.
First Received on September 30, 2005. Last Updated on April 4, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Urinary Bladder, Overactive
More general conditions related to this trial
Lower Urinary Tract Symptoms
Signs and Symptoms
Urinary Bladder Diseases
Interventions listed in this trial
MK-0634 50 mg
MK-0634 125 mg
Placebo for MK-0634
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers